At the RNA Institute, we focus on developing tools and analytics for moving RNA therapeutics down the drug candidate pathway. We disseminate these tools and technologies through collaborations with researchers in a breadth of disciplines and disease focuses, critical to human health.
RNA Institute Director, Dr. Andrew Berglund is attending the Myotonic Dystrophy Foundation’s 2018 Annual Conference on September 14-15 to present new research with clinical significance for myotonic dystrophy (DM) therapies. Dr. Berglund will be presenting his lab’s progress on developing … Continued
Professor J. Andrew Berglund will join the College of Arts and Sciences as Director of the RNA Institute and Professor of Biological Sciences in the Fall of 2018
The Hunt to End Disease ALBANY, N.Y. (March 8, 2018) – UAlbany chemists Max Royzen and Jia Sheng want to better understand how our body’s ribonucleic acid (RNA) can help fight some of the most challenging human diseases such as … Continued
ALBANY, NY (November 8, 2017) Dr. Ken Halvorsen, senior research scientist with The RNA Institute at the University at Albany recently received an Outstanding Investigator Award (R35) from the National Institute of Health. The award of $1.9 million will be … Continued
Detecting Ebola with the naked eye is now possible due to a method developed by a University at Albany research team. The new method means a cost-effective, quick, and easy way to detect Ebola. With the method, detection results occur … Continued
ALBANY, N.Y. (May 11, 2017) –RNA and protein molecules serve as workhorses inside of all cellular organisms. Both play important roles in ensuring our cells function properly and are essential to human life. UAlbany chemists Alan Chen, Maksim Royzen and … Continued